Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Broto

Showing results (451-460 of 555) with videos related to

Pageof 56
Sort By:
ESMO Open|January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysisAndrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
Cancers|October 16, 2025
Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) GuidelinesMaria Angeles Vaz-Salgado, Claudia Valverde-Morales, Rosa Alvarez, et al.
Eclinicalmedicine|May 31, 2019
Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma GroupsAlessandro Gronchi, Nadia Hindi, Josefina Cruz, et al.
Cancer Treatment Reviews|August 2, 2021
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part IIJavier Martínez-Trufero, Josefina Cruz Jurado, C Nieves Hernández-León, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 15, 2015
The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world useJulio Martinez-Cutillas, Carme Alerany-Pardo, Joaquín Borrás-Blasco, et al.
Cancer Treatment Reviews|July 26, 2021
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS - GROUP). Part IJavier Martínez-Trufero, Josefina Cruz Jurado, M Carmen Gómez-Mateo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)J Martin-Broto, A Redondo, C Valverde, et al.
BMJ Open|April 11, 2025
Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)-a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocolEugenia Negredo, Diana Hernández-Sánchez, Patricia Álvarez-López, et al.
The Lancet Regional Health. Europe|May 28, 2026
Incidence and Clinical, Virological, and Resistance Characteristics of HIV Infections Among pre-Exposure Prophylaxis Users in Spain (SCOPE Study): A Multicentre Prospective and Retrospective Cohort StudyMar Vera, Patricia Álvarez-López, Haridian Tato, et al.
Pageof 56

Showing results (451-460 of 555) with videos related to

Sort By:
Pageof 56
ESMO Open|January 21, 2020
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysisAndrea Napolitano, Salvatore Provenzano, Chiara Colombo, et al.
Cancers|October 16, 2025
Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) GuidelinesMaria Angeles Vaz-Salgado, Claudia Valverde-Morales, Rosa Alvarez, et al.
Eclinicalmedicine|May 31, 2019
Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma GroupsAlessandro Gronchi, Nadia Hindi, Josefina Cruz, et al.
Cancer Treatment Reviews|August 2, 2021
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part IIJavier Martínez-Trufero, Josefina Cruz Jurado, C Nieves Hernández-León, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 15, 2015
The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world useJulio Martinez-Cutillas, Carme Alerany-Pardo, Joaquín Borrás-Blasco, et al.
Cancer Treatment Reviews|July 26, 2021
Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS - GROUP). Part IJavier Martínez-Trufero, Josefina Cruz Jurado, M Carmen Gómez-Mateo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)J Martin-Broto, A Redondo, C Valverde, et al.
BMJ Open|April 11, 2025
Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)-a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocolEugenia Negredo, Diana Hernández-Sánchez, Patricia Álvarez-López, et al.
The Lancet Regional Health. Europe|May 28, 2026
Incidence and Clinical, Virological, and Resistance Characteristics of HIV Infections Among pre-Exposure Prophylaxis Users in Spain (SCOPE Study): A Multicentre Prospective and Retrospective Cohort StudyMar Vera, Patricia Álvarez-López, Haridian Tato, et al.
Pageof 56